{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:56:24Z","timestamp":1753890984227,"version":"3.41.2"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Primary hypertension (PHTN) and IgA vasculitis (IgAV) are two prevalent medical conditions that affect the kidneys. Despite their distinct pathophysiological mechanisms, clinical manifestations, and treatment approaches, both conditions significantly impact patients\u2019 quality of life and overall health. Unfortunately, a boy developed hypertensive nephritis (HN) at the age of 4, followed by IgAV nephritis at the age of 10. The exact pathophysiological mechanisms underlying these conditions remain elusive. This study aims to report this unusual case and investigate the biological mechanisms associated with the differentially expressed genes (DEGs) related to PHTN and IgAV through the application of bioinformatics tools.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We present the case of a boy diagnosed with PHTN and IgAV. Additionally, we explore the molecular mechanisms underlying both conditions. DEGs were analyzed, and gene functional enrichment was performed using the DAVID database. A protein-protein interaction (PPI) network was constructed using the STRING database and visualized with Cytoscape software. The hub genes were identified using the MCODE plugin. CIBERSORT was used to assess the expression changes in immune cells and obtain the proportion of various types of immune cells. Furthermore, the Connectivity Map L1000 platform was utilized to identify potential therapeutic agents.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The boy initially presented with malignant hypertension (MHT), and renal biopsy pathology indicated HN. Following regular use of antihypertensive medications, there was a significant improvement in blood pressure (BP), renal function, and the left ventricular hypertrophy index. However, he developed IgAV six years after the diagnosis of PHTN. A subsequent renal biopsy revealed IgAV nephritis, and the pathology associated with HN showed marked improvement. A total of 7,027 DEGs associated with PHTN and 90 DEGs linked to IgAV were identified, with 25 genes overlapping between the two sets. KEGG pathway analysis revealed that the DEGs were primarily associated with extracellular matrix (ECM) receptor interaction. Among EMC key components, fibronectin expression was markedly elevated in hypertensive nephritis and IgA nephropathy. Gene Ontology (GO) biological process analysis indicated that the 25 overlapping DEGs were significantly related to processes such as proteolysis, amyloid fibril formation, cAMP-mediated signaling, synaptic vesicle endocytosis, and receptor internalization. The significantly enriched terms related to changes in the cellular component of DEGs included platelet alpha granule membrane, nucleoplasm, and endocytic vesicle membrane. Changes in molecular function were primarily associated with protein binding. Furthermore, six hub genes implicated in both diseases were linked to cell adhesion molecules. We also found that neutrophils accounted for the majority of all infiltrating cells. And B cell na\u00efve were downregulated in both diseases.Using the Connectivity Map (CMap) database, the top 10 potential therapeutic agents were identified.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We found that aggressive BP-lowering agents were necessary for managing PHTN. This study also reveals the common pathogenesis underlying both PHTN and IgAV. Moving forward, these shared hub genes could serve as novel targets for more in-depth mechanistic investigations and the development of new therapeutic interventions for individuals affected by PHTN and IgAV.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1596174","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T05:23:28Z","timestamp":1749187408000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the shared molecular mechanisms of primary hypertension and IgA vasculitis through a case report and combining bioinformatics analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Qijiao","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haimei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000228","article-title":"Pediatric primary hypertension: an underrecognized condition: A scientific statement from the american heart association","volume":"80","author":"Falkner","year":"2023","journal-title":"Hypertension"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.123.21041","article-title":"Childhood primary hypertension: not uncommon, not benign","volume":"80","author":"Halbach","year":"2023","journal-title":"Hypertension"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1007\/s11033-024-09986-5","article-title":"Relationship between the AGT M235T genetic variant and the characteristics and prognosis of coronary atherosclerosis in patients with acute myocardial infarction","volume":"51","author":"Tran","year":"2024","journal-title":"Mol Biol Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/14779072.2018.1540301","article-title":"Pathophysiology of essential hypertension: an update","volume":"16","author":"Saxena","year":"2018","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2022.07.010","article-title":"Chronic kidney disease in children","volume":"69","author":"VanSickle","year":"2022","journal-title":"Pediatr Clin North Am"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.771619","article-title":"Pathogenesis of igA vasculitis: an up-to-date review","volume":"12","author":"Song","year":"2021","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/MAT.0000000000001477","article-title":"IgA vasculitis with henoch-sch\u00f6nlein purpura as an immune complication associated with left ventricle assist device insertion","volume":"68","author":"Ait-Tigrine","year":"2022","journal-title":"ASAIO J"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.03.029","article-title":"Galactose-deficient IgA1 in skin and serum from patients with skin-limited and systemic IgA vasculitis","volume":"81","author":"Neufeld","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2013update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.8.168","article-title":"Microarray analysis of differential gene expression profile in peripheral blood cells of patients with human essential hypertension","volume":"8","author":"Korkor","year":"2011","journal-title":"Int J Med Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.7038","article-title":"Differential expression of long non-coding RNA and mRNA in children with Henoch-Sch\u00f6nlein purpura nephritis","volume":"17","author":"Pang","year":"2019","journal-title":"Exp Ther Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","article-title":"DAVID: database for annotation, visualization, and integrated discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1179","article-title":"Gene Ontology Consortium: going forward","volume":"43","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"B16","article-title":"PRIMARY HYPERTENSION IN CHILDREN AND ADOLESCENTS","volume":"160","author":"Hamdani","year":"2021","journal-title":"Harefuah"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-020-04579-3","article-title":"Obesity, metabolic syndrome, and primary hypertension","volume":"36","author":"Litwin","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12112622","article-title":"Epigenetics of hypertensive nephropathy","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomedicines"},{"key":"B19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3892\/mmr.2021.11873","article-title":"Mechanism of herbal medicine on hypertensive nephropathy (Review)","volume":"23","author":"Dong","year":"2021","journal-title":"Mol Med Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11926-018-0735-3","article-title":"IgA vasculitis: genetics and clinical and therapeutic management","volume":"20","author":"Gonz\u00e1lez-Gay","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-022-01162-z","article-title":"Update Immunglobulin-A-Vaskulitis [Update on immunoglobulin A vasculitis","volume":"81","author":"Neumann","year":"2022","journal-title":"Z Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-024-06502-6","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis","volume":"40","author":"Vivarelli","year":"2025","journal-title":"Pediatr Nephrol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-021-00464-0","article-title":"Management of igA vasculitis with nephritis","volume":"23","author":"Delbet","year":"2021","journal-title":"Paediatr Drugs"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2016_90","article-title":"Endothelial dysfunction and hypertension","volume":"956","author":"Konukoglu","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10245816","article-title":"Effect of the renin-angiotensin-aldosterone system reactivity on endothelial function and modulative role of valsartan in male subjects with essential hypertension","volume":"10","author":"Jasiczek","year":"2021","journal-title":"J Clin Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1113\/EP088169","article-title":"Hypertension and sympathetic nervous system overactivity rely on the vascular tone of pial vessels of the rostral ventrolateral medulla in spontaneously hypertensive rats","volume":"105","author":"Malheiros-Lima","year":"2020","journal-title":"Exp Physiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.123.21369","article-title":"Salt-sensitive hypertension and the kidney","volume":"81","author":"Nishimoto","year":"2024","journal-title":"Hypertension"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199508001-00007","article-title":"Endothelium-derived vasoactive factors in hypertension: nitric oxide and endothelin","volume":"13","author":"Nava","year":"1995","journal-title":"J Hypertens Suppl"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179706","article-title":"Childhood cardiovascular health, obesity, and some related disorders: insights into chronic inflammation and oxidative stress","volume":"25","author":"Herti\u0161 Petek","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.73443","article-title":"Rheumatoid purpura in children: A retrospective study","volume":"16","author":"Boudarbala","year":"2024","journal-title":"Cureus"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147538","article-title":"IgA vasculitis: etiology, treatment, biomarkers and epigenetic changes","volume":"22","author":"Sugino","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/cells11101625","article-title":"Pathogenic T-cell responses in immune-mediated glomerulonephritis","volume":"11","author":"Linke","year":"2022","journal-title":"Cells"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.943912","article-title":"A review of igA vasculitis (Henoch-sch\u00f6nlein purpura) past, present, and future","volume":"30","author":"Parums","year":"2024","journal-title":"Med Sci Monit"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfad236","article-title":"Urinary markers of the alternative and lectin complement pathway are increased in IgA vasculitis nephritis","volume":"16","author":"Marro","year":"2023","journal-title":"Clin Kidney J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.lpm.2018.11.017","article-title":"Hypertension art\u00e9rielle permanente essentielle: d\u00e9finitions et revue h\u00e9modynamique, clinique et th\u00e9rapeutique [Essential hypertension: Definitions, hemodynamic, clinical and therapeutic review","volume":"48","author":"Vall\u00e9e","year":"2019","journal-title":"Presse Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4249","article-title":"Association of blood pressure lowering with incident dementia or cognitive impairment: A systematic review and meta-analysis","volume":"323","author":"Hughes","year":"2020","journal-title":"JAMA"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065446","article-title":"Eptifibatide, an older therapeutic peptide with new indications: from clinical pharmacology to everyday clinical practice","volume":"24","author":"Tonin","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3892\/mmr.2024.13224","article-title":"Dicoumarol attenuates NLRP3 inflammasome activation to inhibit inflammation and fibrosis in knee osteoarthritis","volume":"29","author":"Ge","year":"2024","journal-title":"Mol Med Rep"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/nu13082704","article-title":"Nutritional supplements and neuroprotective diets and their potential clinical significance in post-stroke rehabilitation","volume":"13","author":"Zieli\u0144ska-Nowak","year":"2021","journal-title":"Nutrients"},{"key":"B40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.intimp.2012.05.021","article-title":"Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis","volume":"14","author":"Th\u00f6ne","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199957030-00014","article-title":"Troglitazone: a review of its use in the management of type 2 diabetes mellitus","volume":"57","author":"Plosker","year":"1999","journal-title":"Drugs"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/boc.201400087","article-title":"(Salirasib) efficiency via combinatorial treatment","volume":"107","author":"Wolfson","year":"2015","journal-title":"Biol Cell"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199711020-00008","article-title":"Terazosin. A pharmacoeconomic evaluation of its use in benign prostatic hyperplasia","volume":"11","author":"Plosker","year":"1997","journal-title":"Pharmacoeconomics"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2332956","article-title":"Febuxostat provides renoprotection in patients with hyperuricemia or gout: a systematic review and meta-analysis of randomized controlled trials","volume":"56","author":"Yang","year":"2024","journal-title":"Ann Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00604.2020","article-title":"The intersection of metformin and inflammation","volume":"320","author":"Bharath","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101690","article-title":"The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy","volume":"5","author":"Hu","year":"2024","journal-title":"Cell Rep Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1596174\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T05:23:29Z","timestamp":1749187409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1596174\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2025.1596174"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1596174","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"article-number":"1596174"}}